1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Ovarian Cancer Treatment Drugs Markets in China

Ovarian Cancer Treatment Drugs Markets in China

  • March 2016
  • -
  • Asia Market Information & Development Company
  • -
  • 272 pages

China's demand for Ovarian Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2005, 2010 and 2015) and long-term forecasts through 2020 and 2025 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

Table Of Contents

Ovarian Cancer Treatment Drugs Markets in China
TABLE OF CONTENTS



I. INTRODUCTION

Report Scope and Methodology
Executive Summary

II. BUSINESS ENVIRONMENT

Economic Outlook

Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade

Financial and Tax Regulations

Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

Ovarian Cancer Treatment Drugs Industry Structure
Market Size
Market Growth Drivers
Ovarian Cancer Treatment Drugs Sales Volume
Major Producer Facility Locations
Major Producers' Sales Volume and Market Share
Paclitaxel
Platinum Anticancer Drugs
Fluoropyrimidines
Anthracycline Antibiotics
Therapertic Antibody
Small Molecules Drug
Aromatase Inhibitors (Targeted Therapy Drug)
Anti-estrogens
Aromatase Inhibitors (Endocrine Therapy Drug)
LH-RH
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investment
Technology Development


IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Overview

Ovarian Cancer Treatment Drugs Sales Volume

Chemotherapeutic Drug
Paclitaxel
Fluoropyrimidines
Anthracycline Antibiotics
Platinum Anticancer Drugs

Targeted Therapy Drug
Therapertic Antibody
Small Molecules Drug
Aromatase Inhibitors (Targeted Therapy Drug)

Endocrine Therapy Drug
Anti-estrogens
Aromatase Inhibitors (Endocrine Therapy Drug)
LH?RH

Ovarian Cancer Treatment Drugs Import

Chemotherapeutic Drug
Anthracycline Antibiotics
Fluoropyrimidines
Paclitaxel
Platinum Anticancer Drugs

Targeted Therapy Drug
Therapertic Antibody
Small Molecules Drug
Aromatase Inhibitors (Targeted Therapy Drug)

Endocrine Therapy Drug
Anti-estrogens
Aromatase Inhibitors (Endocrine Therapy Drug)
LH?RH

Pricing Trend


V. OVARIAN CANCER TREATMENT DRUGS MARKET OUTLOOK

Ovarian Cancer Treatment Drugs Markets Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits


VI. MARKET ENTRY CHANNELS

China Market Entry Overview
China's Distribution System
Ovarian Cancer Treatment Drugs Distribution Channels
Transportation and Freight Infrastructure
Communications

China's Market Entry
Licensing
Franchising
E-commerce
Trading Companies and Local Agents
Representative Offices and Chinese Subsidiaries
Wholly Foreign Owned Enterprises


VII. OVARIAN CANCER TREATMENT DRUGS PRODUCER DIRECTORY

Ovarian Cancer Treatment Drugs Producer Profiles and Directory


LIST OF TABLES


I. INTRODUCTION

Economic Outlook Summary

II. BUSINESS ENVIRONMENT

Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade


III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS


Chemotherapeutic Drug Sales Volume and Market Share by Drugs Classification
Targeted Therapy Drug Sales Volume and Market Share by Drugs Classification
Endocrine Therapy Drug Sales Volume and Market Share by Drugs Classification
Ovarian Cancer Treatment Drugs Sales Volume
Major Producer Facility Location
Major Ovarian Cancer Treatment Drugs Producer Sales Volume and Market Share
Major Foreign Investments in China


IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Ovarian Cancer Treatment Drugs Sales Volume
Chemotherapeutic Drug Major Producer and Their Market Share
Chemotherapeutic Drug Sales Volume and Market Share by Drugs Classification

Chemotherapeutic Drug Major Producer and Their Market Share
Paclitaxel Major Producer and Their Market Share
Fluoropyrimidines Major Producer and Their Market Share
Anthracycline Antibiotics Major Producer and Their Market Share
Platinum Anticancer Drugs Major Producer and Their Market Share
Targeted Therapy Drug Major Producer and Their Market Share
Targeted Therapy Drug Sales Volume and Market Share by Drugs Classification
Therapertic Antibody Major Producer and Their Market Share
Small Molecules Drug Major Producer and Their Market Share
Aromatase Inhibitors (Targeted Therapy Drug) Major Producer and Their Market Share
Endocrine Therapy Drug Sales Volume and Market Share by Drugs Classification
Endocrine Therapy Drug Major Producer and Their Market Share
Anti-estrogens Major Producer and Their Market Share
Aromatase Inhibitors (Endocrine Therapy Drug) Major Producer and Their Market Share
LH?RH Major Producer and Their Market Share
Ovarian Cancer Treatment Drugs Import




V. OVARIAN CANCER TREATMENT DRUGS MARKET OUTLOOK

Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits



LIST OF CHARTS


I. INTRODUCTION

Ovarian Cancer Treatment Drugs Sales Volume

II. BUSINESS ENVIRONMENT

China's GDP and Growth Rate
Industrial Output by Ownership
China's Imports and Exports


III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

Chemotherapeutic Drug Market Share by Drugs Classification
Targeted Therapy Drug Market Share by Drugs Classification
Endocrine Therapy Drug Market Share by Drugs Classification
Ovarian Cancer Treatment Drugs Sales Volume

IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Ovarian Cancer Treatment Drugs Sales Volume
Chemotherapeutic Drug Sales Volume and Market Share
Chemotherapeutic Drug Sales Volume by Drugs Classification
Paclitaxel Sales Volume and Market Share
Fluoropyrimidines Sales Volume and Market Share
Anthracycline Antibiotics Sales Volume and Market Share
Platinum Anticancer Drugs Sales Volume and Market Share
Targeted Therapy Drug Sales Volume and Market Share
Targeted Therapy Drug Sales Volume by Drugs Classification
Therapertic Antibody Sales Volume and Market Share
Small Molecules Drug Sales Volume and Market Share
Aromatase Inhibitors (Targeted Therapy Drug) Sales Volume and Market Share

Endocrine Therapy Drug Sales Volume and Market Share
Endocrine Therapy Drug Sales Volume by Drugs Classification
Anti-estrogens Sales Volume and Market Share
Progesterone Sales Volume and Market Share
Aromatase Inhibitors (Endocrine Therapy Drug) Sales Volume and Market Share
LH?RH Sales Volume and Market Share
Ovarian Cancer Treatment Drugs Import
Chemotherapeutic Drug Import and Market Share
Chemotherapeutic Drug Import by Drugs Classification
Paclitaxel Import and Market Share
Anthracycline Antibiotics Import and Market Share
Fluoropyrimidines Import and Market Share
Placlitaxel Anticancer Drugs Import and Market Share
Platinum Anticancer Drugs Import and Market Share
Targeted Therapy Drug Import and Market Share
Targeted Therapy Drug Import by Drugs Classification
Therapertic Antibody Import and Market Share
Small Molecules Drug Import and Market Share
Aromatase Inhibitors (Targeted Therapy Drug) Import and Market Share
Endocrine Therapy Drug Import and Market Share
Endocrine Therapy Drug Import by Drugs Classification
Anti-estrogens Import and Market Share
Progesterone Import and Market Share
Aromatase Inhibitors (Endocrine Therapy Drug) Import and Market Share
LH?RH Import and Market Share


VI. MARKETING STRATEGIES

China's Distribution Channel

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.